BRWA
REGN icon

B. Riley Wealth Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

B. Riley Wealth Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$261K Buy
414
+89
+27% +$60.6K 0.01% 673
2026
Q1 		$244K Buy
325
+24
+8% +$18.4K 0.02% 649
2025
Q4 		$233K Sell
301
-73
-20% -$49.6K 0.01% 803
2025
Q3 		$210K Buy
+374
New +$211K 0.01% 877
2024
Q4 		$231K Sell
324
-392
-55% -$329K 0.01% 975
2024
Q3 		$739K Sell
716
-370
-34% -$412K 0.02% 596
2024
Q2 		$1.14M Buy
1,086
+80
+8% +$77.6K 0.03% 493
2024
Q1 		$828K Sell
1,006
-158
-14% -$150K 0.02% 592
2023
Q4 		$1.02M Buy
1,164
+158
+16% +$130K 0.03% 521
2023
Q3 		$828K Sell
1,006
-83
-8% -$65.2K 0.02% 592
2023
Q2 		$782K Sell
1,089
-237
-18% -$183K 0.02% 662
2023
Q1 		$1.09M Buy
1,326
+27
+2% +$20.4K 0.03% 522
2022
Q4 		$938K Sell
1,299
-388
-23% -$286K 0.03% 558
2022
Q3 		$1.16M Buy
1,687
+37
+2% +$23.3K 0.04% 460
2022
Q2 		$975K Buy
1,650
+45
+3% +$29.3K 0.04% 430
2022
Q1 		$1.12M Sell
1,605
-61
-4% -$38.6K 0.04% 449
2021
Q4 		$1.05M Buy
1,666
+112
+7% +$68.9K 0.03% 515
2021
Q3 		$940K Buy
1,554
+1,088
+233% +$675K 0.03% 537
2021
Q2 		$259K Sell
466
-45
-9% -$22.8K 0.01% 1107
2021
Q1 		$243K Buy
+511
New +$249K 0.01% 1104
2020
Q4 		– Sell
-1,106
Closed -$651K – 1084
2020
Q3 		$651K Buy
1,106
+464
+72% +$281K 0.03% 438
2020
Q2 		$402K Sell
642
-81
-11% -$46K 0.03% 526
2020
Q1 		$354K Sell
723
-255
-26% -$105K 0.03% 490
2019
Q4 		$368K Sell
978
-23
-2% -$7.74K 0.03% 524
2019
Q3 		$278K Buy
1,001
+111
+12% +$32.8K 0.03% 615
2019
Q2 		$279K Buy
890
+58
+7% +$19.3K 0.03% 593
2019
Q1 		$343K Sell
832
-1,857
-69% -$765K 0.04% 449
2018
Q4 		$1.01M Buy
2,689
+1,218
+83% +$446K 0.14% 152
2018
Q3 		$595K Buy
1,471
+707
+93% +$269K 0.07% 306
2018
Q2 		$264K Buy
764
+43
+6% +$13.4K 0.03% 518
2018
Q1 		$249K Sell
721
-68
-9% -$23.7K 0.03% 511
2017
Q4 		$297K Sell
789
-2
-0.3% -$810 0.04% 454
2017
Q3 		$354K Sell
791
-65
-8% -$30.9K 0.06% 337
2017
Q2 		$421K Buy
856
+26
+3% +$11.4K 0.08% 283
2017
Q1 		$322K Sell
830
-56
-6% -$20.8K 0.06% 317
2016
Q4 		$326K Sell
886
-223
-20% -$84.8K 0.07% 328
2016
Q3 		$446K Hold
1,109
– – 0.09% 293
2016
Q2 		$388K Buy
1,109
+265
+31% +$102K 0.08% 320
2016
Q1 		$304K Sell
844
-726
-46% -$299K 0.07% 351
2015
Q4 		$854K Buy
1,570
+196
+14% +$106K 0.17% 156
2015
Q3 		$640K Buy
1,374
+150
+12% +$80.6K 0.15% 181
2015
Q2 		$625K Buy
1,224
+224
+22% +$109K 0.16% 176
2015
Q1 		$451K Sell
1,000
-630
-39% -$267K 0.11% 249
2014
Q4 		$5.25K Buy
+1,630
New +$641K 0.11% 233
2014
Q3 		– Sell
-148
Closed -$41.8K – 1607
2014
Q2 		$41.8K Buy
+148
New +$43.9K 0.01% 1109

Other funds holding REGN

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
HCM
Howland Capital Management Boston, Massachusetts $2.77B AUM 19.56% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

B. Riley Wealth Advisors's REGN Position: Q2 2026 in Review

B. Riley Wealth Advisors increased its Regeneron Pharmaceuticals (REGN) stake by 27% in Q2 2026, buying an estimated $60.6K and bringing the position to 414 shares worth $261K. The position accounts for 0.01% of the portfolio, ranked #673.

B. Riley Wealth Advisors first reported a position in REGN in Q2 2014 and has held it in 45 quarters since. The position peaked at $1.16M in Q3 2022. 208 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • B. Riley Wealth Advisors held 414 shares of Regeneron Pharmaceuticals worth $261K as of Q2 2026.
  • B. Riley Wealth Advisors bought 89 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $60.6K.
  • Regeneron Pharmaceuticals made up 0.01% of B. Riley Wealth Advisors's portfolio in Q2 2026, its #673 holding.
  • B. Riley Wealth Advisors first reported a position in Regeneron Pharmaceuticals in Q2 2014 and has held it in 45 quarters since.
  • B. Riley Wealth Advisors's Regeneron Pharmaceuticals position peaked at $1.16M in Q3 2022.
  • 208 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on B. Riley Wealth Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.